🇺🇸 inactivated split-virus influenza vaccine in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Interaction — 2 reports (18.18%)
  2. Anaemia — 1 report (9.09%)
  3. Contusion — 1 report (9.09%)
  4. Ecchymosis — 1 report (9.09%)
  5. Haematoma — 1 report (9.09%)
  6. Haemoptysis — 1 report (9.09%)
  7. International Normalised Ratio Decreased — 1 report (9.09%)
  8. Pain In Extremity — 1 report (9.09%)
  9. Peripheral Swelling — 1 report (9.09%)
  10. Platelet Count Decreased — 1 report (9.09%)

Source database →

Other Immunology approved in United States

Frequently asked questions

Is inactivated split-virus influenza vaccine approved in United States?

inactivated split-virus influenza vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for inactivated split-virus influenza vaccine in United States?

The Cleveland Clinic is the originator. The local marketing authorisation holder may differ — check the official source linked above.